What MID Labs transfer means for Hoya stock
Published on 10/17/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTransfer and delivery date
- HOYA agreed to transfer MID Labs shares on October 9, 2026.
- The transaction covers 3,648,539 shares and leaves HOYA with zero shares.
- Bausch + Lomb is scheduled to receive the shares on November 2, 2026.
HOYA agreed on October 9, 2026, to transfer all shares of its subsidiary Medical Instrument Development Laboratories, Inc., known as MID Labs, to Bausch + Lomb. The announcement was reported by Japan IR.
Market context: Market report Nikkei 225.
The announced transfer
The transaction covers 3,648,539 shares. HOYA is expected to hold zero MID Labs shares after completion, while Bausch + Lomb is expected to hold an 88 percent stake. The share delivery is scheduled for November 2, 2026, according to Japan IR.
Weekend trading
Lang & Schwarz recorded the Hoya instrument at EUR 143.05 on October 16, 2026, with the quote timestamped at 10:57 p.m. CEST. The next price is shown from the start of trading by the continuously updated real-time quote of Hoya stock.
Expected completion
HOYA said the transfer is expected to have a minor impact on consolidated results for the current fiscal year. The transaction is being implemented as part of the group’s business portfolio strategy, with completion scheduled for November 2, 2026. These details were reported by Japan IR.
